TriangleNCT00426764 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- clinicaltrialdisclosure@celgene.com
- organization
- Celgene Corporation
- phone
- 1-888-260-1599
- title
- Associate Director, Clinical Trials Disclosure
Complete source fields
- certain Agreement
- other Details
- Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- clinicaltrialdisclosure@celgene.com
- organization
- Celgene Corporation
- phone
- 1-888-260-1599
- title
- Associate Director, Clinical Trials Disclosure
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice